Chris Coons actually said...

I think biochemical, pharmaceutical, I think anything in the medical field will all be very good targets for this.

That will be a massive change. We had it in 2010 for one year. It was just a sea change for folks being able to take it across the board.

The reason small businesses cannot take the R&D credit, the key reason is the AMT.

hey, we are going to make the R&D credit available for startups, starts being the driver for both innovation and for new jobs in this countr...